Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Methotrexate for inflammatory bowel disease: time for reconsideration

Research output: Contribution to journalJournal articleResearchpeer-review

  1. An update on cirrhotic cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Glucagon like peptide-2 and neoplasia; a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects

    Research output: Contribution to journalReviewResearchpeer-review

  4. Advances in the treatment of portal hypertension in cirrhosis

    Research output: Contribution to journalReviewResearchpeer-review

  5. The role and advances of immunomodulator therapy for inflammatory bowel disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Severe ulcerative oesophagitis caused by primary Epstein-Barr virus infection in an immunocompetent individual

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A fully defined 3D matrix for ex vivo expansion of human colonic organoids from biopsy tissue

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mucosal vitamin D signaling in inflammatory bowel disease

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations
Original languageEnglish
JournalExpert review of gastroenterology & hepatology
Volume13
Issue number5
Pages (from-to)407-409
Number of pages3
ISSN1747-4124
DOIs
Publication statusPublished - May 2019

    Research areas

  • Anti-Inflammatory Agents/adverse effects, Biological Products/therapeutic use, Clinical Decision-Making, Colitis, Ulcerative/diagnosis, Combined Modality Therapy, Crohn Disease/diagnosis, Evidence-Based Medicine, Gastrointestinal Agents/adverse effects, Humans, Methotrexate/adverse effects, Patient Selection, Remission Induction, Treatment Outcome

ID: 59002508